First Patients Dosed in Doron’s Knee OA Study of MOTYS
The Phase 3 trial is evaluating the single-injection biologic candidate for improvements in pain and function....
Oct 16, 2025,
First Patients Dosed in Doron’s Knee OA Study of MOTYS
J&J MedTech Reports 3Q, Announces Ortho Spin-off
Along with its third quarter earnings, J&J MedTech announced its intent to separate its orthopedics business into a standalone company....
Oct 15, 2025,
Globus Medical Launches ANTHEM Elbow Fracture System
ANTHEM Elbow is designed to offer surgeons anatomically-contoured plates to treat a variety of fractures, regardless of severity or complexity,...
Oct 15, 2025,
Spartan Medical and Reign Medical Enter Strategic Partnership
The companies will join forces with the Clench Compression Staple, a fully disposable fixation device for orthopedic and podiatric surgeons....
Oct 15, 2025,
Centinel Spine Gains 2-Level FDA Approval for prodisc Devices
The prodisc C Vivo and prodisc C SK are now indicated for reconstruction of a vertebral disc from C3-C7 following...
Oct 14, 2025,
Orthopedic Funding Remains Strong Despite Slower Pace
The number of orthopedic investments continues to fall, but the total dollar amount available to companies has actually grown since...
Oct 14, 2025,
J&J MedTech to Spin Off Orthopedics Business
J&J MedTech announced it will spin off its orthopedics business into a stand alone company called DePuy Synthes within the...
Oct 14, 2025,
J&J MedTech Launches INHANCE INTACT
The total shoulder replacement system is designed for tissue-sparing surgery, providing same day post-op mobility. ...
Oct 13, 2025,
What We’re Watching: 2025 Third Quarter Results
In this short video, we look at first half market performance, foot and ankle volumes, and companies in the middle...
Oct 13, 2025,
Surgical Theater Receives FDA Clearance for SyncAR Spine
SyncAR integrates with Medtronic StealthStation navigation and incorporates AI-driven vertebra segmentation with various elements to keep pre-op models aligned with...
Oct 10, 2025,
Loading new posts...
No more posts
